Nephros Inc (NEPH)

2.19 0.00 (0.00%) USD  |  NASDAQ  |  Apr 25, 16:00
More

Nephros Research and Development Expense (Quarterly): 0.208M for Dec. 31, 2023

Research and Development Expense (Quarterly) Chart

Historical Research and Development Expense (Quarterly) Data

View and export this data back to 2004. Upgrade now.
Date Value
December 31, 2023 0.208M
September 30, 2023 0.205M
June 30, 2023 0.221M
March 31, 2023 0.239M
December 31, 2022 0.359M
September 30, 2022 0.252M
June 30, 2022 0.273M
March 31, 2022 0.372M
December 31, 2021 0.328M
September 30, 2021 0.395M
June 30, 2021 0.487M
March 31, 2021 0.556M
December 31, 2020 0.609M
September 30, 2020 0.751M
June 30, 2020 0.836M
March 31, 2020 0.563M
December 31, 2019 0.764M
September 30, 2019 0.777M
June 30, 2019 0.793M
March 31, 2019 0.756M
December 31, 2018 0.546M
September 30, 2018 0.352M
June 30, 2018 0.352M
March 31, 2018 0.289M
December 31, 2017 0.258M
Date Value
September 30, 2017 0.237M
June 30, 2017 0.277M
March 31, 2017 0.231M
December 31, 2016 0.316M
September 30, 2016 0.241M
June 30, 2016 0.254M
March 31, 2016 0.269M
December 31, 2015 0.244M
September 30, 2015 0.226M
June 30, 2015 0.164M
March 31, 2015 0.192M
December 31, 2014 0.26M
September 30, 2014 0.178M
June 30, 2014 0.18M
March 31, 2014 0.163M
December 31, 2013 0.18M
September 30, 2013 0.204M
June 30, 2013 0.259M
March 31, 2013 0.223M
December 31, 2012 0.08M
September 30, 2012 0.208M
June 30, 2012 0.199M
March 31, 2012 0.145M
December 31, 2011 0.074M
September 30, 2011 0.137M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

0.205M
Minimum
Sep 2023
0.836M
Maximum
Jun 2020
0.4731M
Average
0.395M
Median
Sep 2021

Research and Development Expense (Quarterly) Benchmarks

Perspective Therapeutics Inc 6.08M
Retractable Technologies Inc 0.1617M
Xtant Medical Holdings Inc 0.492M
Asensus Surgical Inc 8.614M
Catheter Precision Inc -0.011M